Pubdate: Wed, 21 Apr 1999 Source: San Jose Mercury News (CA) Copyright: 1999 Mercury Center Contact: http://www.sjmercury.com/ Author: Susan Okie, Washington Post DIETARY AID'S DANGERS COME TO LIGHT A MUSCLE builder. A fat burner. A sleep aid. An aphrodisiac. A natural "high." Claims like those helped boost sales of gamma butyrolactone (GBL), a dietary supplement that the Food and Drug Administration asked manufacturers to recall in January because of at least 55 cases of serious illness, including users who suffered seizures, coma and respiratory arrest. At least one person has died after taking GBL, which the FDA considers a dangerous, unapproved drug. Sold over the Internet and in gyms and health food stores, products containing GBL gained popularity last year because the supplement produced the same effects as gamma hydroxybutyrate or GHB, a banned chemical cousin. Never an approved drug, GHB had attracted bodybuilders and wrestlers as an alternative to steroids for "bulking up" muscles, as well as recreational users intrigued by its odd combination of sedative and stimulatory effects on the brain. It also became notorious as a date rape drug. GHB's production and sale were banned in 1991 after it was linked to numerous cases of serious illness and some deaths. Variety of uses Last summer, cases like those associated with GHB -- comas, unexplained seizures, people with dangerously slow heartbeats or breathing -- began showing up in GBL users, said Mary Palmer, a toxicologist working on a large study of illness and poisoning in dietary supplement users. There are no reliable figures on how many people have taken GBL, whose primary use is as a solvent in products such as floor stripper, paint thinner and nail-polish remover. It goes by various chemical names and is an ingredient in several dietary supplement products. The similar symptom profile is easy to explain: GBL is chemically converted by the body into GHB, the banned drug. "The seemingly less-worrisome supplement becomes converted into something that's very worrisome," said Gary I. Wadler, an associate professor of Clinical Medicine at New York University School of Medicine and lead author of a textbook on drugs and the athlete. Wadler said the recent popularity of GBL resembles the situation with androstenedione, another over-the-counter supplement taken by some athletes, which the body converts into testosterone, a prescription hormone. In both cases, he noted, the laxity of the law regulating dietary supplements allows people easy access to substances that can act like powerful drugs and may pose serious risks to their health. The banned GHB has a dual action on the brain. Like cocaine, it stimulates nerve cells that respond to the chemical messenger dopamine, producing an excitatory effect. Like heroin, it activates natural opium-like substances within the brain, causing sedation. Taking GHB "is sort of like taking heroin and cocaine at the same time," Wadler said. The result can be a perplexing set of symptoms. Palmer recalled the case of a New York topless dancer. "She did her dance, got offstage and she dropped. She came into the emergency room in a coma." Doctors inserted a breathing tube. They discovered that her heart rate was 50 - -- alarmingly slow. Then she developed an irregular heartbeat. When she woke up, she admitted that she had taken GHB. Examples of its effects GBL apparently can produce a similar spectrum of effects. Arizona doctors reported the case last September of a 36-year-old man who was stopped for driving erratically and was found to be sweating, vomiting and lethargic. He acted drunk, but tests for alcohol and illicit drugs were negative. He recovered within an hour and reported that he had taken two ounces of RenewTrient, a GBL-containing product. GBL never should have been marketed as a dietary supplement because it was a new ingredient that had been clearly shown to have dangerous effects in human and animal studies, said Annette Dickinson, vice president for scientific and regulatory affairs of the Council for Responsible Nutrition, a trade association representing about 100 supplement manufacturers. "We don't see how anyone could reasonably conclude that it would be safe at the kind of levels that were recommended" on product labels, she said. In January, the FDA announced that three manufacturers of GBL-containing supplements -- G.H. Distributors Inc., Trimfast Group Inc. and Conan Corp./Castlewood Nutritional Systems -- had agreed to the voluntary recall. The agency has sent letters to four other companies, warning of possible legal action against their products if they do not cooperate. Paul A. Cotton, a sports nutritionist and the head wrestling coach at Howard University, said GBL is "mildly popular" in the wrestling community, whose athletes often are attracted to substances that they believe will give them a competitive edge. He said he had counseled athletes who had tried GBL but hadn't encountered any cases of illness. They're "a little bit secretive about what they're taking," he added. Cotton said he warns his athletes that purity and manufacturing standards for dietary supplements have not been set by the government. "I kind of equate it to buying street drugs," he said. - --- MAP posted-by: Derek Rea